Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / JNJ - Genmab reports Q2 worldwide net sales of DARZALEX $1.99B


JNJ - Genmab reports Q2 worldwide net sales of DARZALEX $1.99B

  • Genmab ( GMAB ) said global net sales of Darzalex reported by Johnson & Johnson ( JNJ ) rose 38.6% to $1.99B in Q2.
  • Net trade sales were USD 1.02B in the U.S. and $965M in the rest of the world.
  • Genmab receives royalties on the worldwide net sales of Darzalex, both the intravenous and subcutaneous formulations, under an license agreement with J&J unit Janssen Biotech.
  • Shares are up 2.84% premarket.

For further details see:

Genmab reports Q2 worldwide net sales of DARZALEX $1.99B
Stock Information

Company Name: Johnson & Johnson
Stock Symbol: JNJ
Market: NYSE
Website: jnj.com

Menu

JNJ JNJ Quote JNJ Short JNJ News JNJ Articles JNJ Message Board
Get JNJ Alerts

News, Short Squeeze, Breakout and More Instantly...